Search

Your search keyword '"Neisseria gonorrhoeae immunology"' showing total 1,134 results

Search Constraints

Start Over You searched for: Descriptor "Neisseria gonorrhoeae immunology" Remove constraint Descriptor: "Neisseria gonorrhoeae immunology"
1,134 results on '"Neisseria gonorrhoeae immunology"'

Search Results

1. Exploring Candesartan, an angiotensin II receptor antagonist, as a novel inhibitor of NLRP3 inflammasome: alleviating inflammation in Neisseria gonorrhoeae infection.

2. Tackling immunosuppression by Neisseria gonorrhoeae to facilitate vaccine design.

3. Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context.

4. Development and Validation of Multiplex Assays for Mouse and Human IgG and IgA to Neisseria gonorrhoeae Antigens.

5. Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis.

6. Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK.

7. The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial.

8. Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

9. Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development.

10. Vaccine value profile for Neisseria gonorrhoeae.

11. Dual species transcriptomics reveals conserved metabolic and immunologic processes in interactions between human neutrophils and Neisseria gonorrhoeae.

12. Vaccination May Be Economically and Epidemiologically Advantageous Over Frequent Screening for Gonorrhea Prevention.

13. Characterization of Neisseria gonorrhoeae colonization of macrophages under distinct polarization states and nutrients environment.

14. Sweet complexity: O -linked protein glycosylation in pathogenic Neisseria .

15. Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol.

16. Neisseria gonorrhoeae scavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation.

17. Peptidoglycan fragment release and NOD activation by commensal Neisseria species from humans and other animals.

18. IL-17C is a driver of damaging inflammation during Neisseria gonorrhoeae infection of human Fallopian tube.

19. Experimental Urethral Infection with Neisseria gonorrhoeae.

20. Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence.

21. Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme.

22. Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets.

23. Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.

24. Challenges and Controversies Concerning Neisseria gonorrhoeae-Neutrophil Interactions in Pathogenesis.

25. Enhancement of immune responses by co-administration of bacterial ghosts-mediated Neisseria gonorrhoeae DNA vaccines.

26. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.

27. Neisseria gonorrhoeae Multivalent Maxibody with a Broad Spectrum of Strain Specificity and Sensitivity for Gonorrhea Diagnosis.

28. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.

29. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.

30. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.

31. Inhibition of TLR2/TLR4 alleviates the Neisseria gonorrhoeae infection damage in human endometrial epithelial cells via Nrf2 and NF-Kβsignaling.

32. Modulation of phagocytosis-induced cell death of human neutrophils by Neisseria gonorrhoeae.

33. Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae .

34. Is it time to use nucleic acid amplification tests for identification of persons with sexually transmitted infections?: evidence from seroprevalence and behavioral epidemiology risk surveys in men with chlamydia and gonorrhea.

35. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.

37. The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.

38. A vaccine for meningococcal B disease and gonorrhoea.

39. Altering the Neisseria gonorrhoeae pilE Guanine Quadruplex Loop Bases Affects Pilin Antigenic Variation.

40. Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.

41. Biological feasibility and importance of a gonorrhea vaccine for global public health.

42. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.

43. Progress Toward a Gonococcal Vaccine: The Way Forward.

44. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.

45. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.

46. The novel interaction between Neisseria gonorrhoeae TdfJ and human S100A7 allows gonococci to subvert host zinc restriction.

47. Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by Neisseria gonorrhoeae in Macrophages.

48. Location, Location, Location-Commensalism, Damage and Evolution of the Pathogenic Neisseria.

49. Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.

50. Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines.

Catalog

Books, media, physical & digital resources